Givinostat and hydroxyurea synergize in vitro to induce apoptosis of cells from JAK2V617F myeloproliferative neoplasm patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Givinostat and hydroxyurea synergize in vitro to induce apoptosis of cells from JAK2V617F myeloproliferative neoplasm patients

Published:2013-03 Issue:3 Volume:41 Page:253-260.e2
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Amaru Calzada Ariel,Pedrini Olga,Finazzi Guido,Leoni Flavio,Mascagni Paolo,Introna Martino,Rambaldi Alessandro,Golay Josée

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference41 articles.

1. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management;Tefferi;Am J Hematol,2012

2. JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science;Kilpivaara;Leukemia,2008

3. Chronic myeloproliferative neoplasms and subsequent cancer risk: A Danish population-based cohort study;Frederiksen;Blood,2011

4. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis;Cortelazzo;N Engl J Med,1995

5. From efficacy to safety: A Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera;Fruchtman;Semin Hematol,1997

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of 1,10-phenanthroline-based hydroxamate derivative as dual histone deacetylases/ribonucleotide reductase inhibitor with antitumor activities;DARU Journal of Pharmaceutical Sciences;2024-04-29

2. Synergistic therapeutics: Co-targeting histone deacetylases and ribonucleotide reductase for enhanced cancer treatment;European Journal of Medicinal Chemistry;2024-04

3. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies;Signal Transduction and Targeted Therapy;2023-02-17

4. The role of protein acetylation in carcinogenesis and targeted drug discovery;Frontiers in Endocrinology;2022-09-12

5. Atorvastan, Apsirin and Hydorxyurea for an Effective and Low-Cost Treatment in High-Risk Polycythemia Vera;EMJ Hematology;2022-01-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3